JohnNCavinessMD

PubMed

• 357 citations
  Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
  Charles H. Adler, Thomas G. Beach, Joseph G. Hentz, Holly A. Shill, John N. Caviness
  Neurology. 2014-07-29
• 37 citations
  Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts.
  John N. Caviness, Rene L. Utianski, J. G. Hentz, Thomas G. Beach, Brittany N. Dugger
  European Journal of Neurology. 2016-02-01
• 317 citations
  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
  Thomas G. Beach, Charles H. Adler, Lucia I. Sue, Geidy E. Serrano, Holly A. Shill
  Neuropathology. 2015-08-01

Journal Articles

• Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease  
  Caviness JN, Hentz JG, Belden CM, Shill HA, Driver-Dunckley ED, Sabbagh MN, Powell JJ, Adler CH, Journal of Parkinson's Disease, 1/1/2015
• Alpha-synuclein pathology in sensory nerve terminals of the upper aerodigestive tract of Parkinson's disease patients  
  Mu LC, Chen JM, Sobotka S, Nyirenda T, Benson B, Gupta F, Sanders I, Adler CH, Caviness JN, Shill HA, Sabbagh M, Samanta JE, Sue LI, Beach TG, Dysphagia, 1/1/2015
• The Arizona Parkinson's Disease Consortium Concomitant pathologies among a spectrum of parkinsonian disorders  
  Dugger BN, Adler CH, Shill HA, Caviness JN, Jacobson S, Driver-Dunckley E, Beach TG, Parkinsonism Relat Disord, 1/1/2014
• Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers  
  Dugger BN, Hentz JG, Adler CH, Sabbagh MN, Shill HA, Jacobson S, Caviness JN, Belden C, Driver-Dunckley E, Davis KJ, Sue LI, Beach TG, J Neuropathol Exp Neurol, 1/1/2014
• Results of the citalopram to enhance cognition in Huntington disease trial  
  Beglinger LJ, Adams WH, Langbehn D, Fiedorowicz JG, Jorge R, Biglan K, Caviness J, Olson B, Robinson RG, Kieburtz K, Paulsen JS, Mov Disord, 1/1/2014
• Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects  
  Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Cuenca N, Arizona Parkinson's Disease Consortium, Neurosci Lett, 1/1/2014
• Clinical and neuropathological correlates of visual hallucinations in parkinsonism  
  Morshed T, Jacobson S, Beach TG, Adler C, Hu CC, Shill H, Caviness J, Belden C, Davis KJ, Sue LI, Sabbagh MN, Am J Geriatr Psychiatry, 1/1/2013
• A cognitive-perceptual approach to conceptualizing speech intelligibility deficits and remediation practice in hypokinetic dysarthria  
  Lansford, K.L., Liss, J.M., Caviness, J.N., & Utianski, R.L., Parkinson’s Disease, 1/1/2011
• Predictors of diagnosis in Huntington disease  
  Langbehn DR, Paulsen JS, Hedges P, McCusker E, Pearce S, Trent R, Abwender D, Como P, Gardiner I, Hickey C, Kayson E, Kieburtz K, Marshall F, Pearson N, Shoulson I, Zi..., Neurology, 1/1/2007
• An exploration of familiarization effects in the perception of hypokinetic and ataxic dysarthic speech  
  Spitzer SM, Liss JM, Caviness JN, Adler CH, J of Med Speech-Language Path, 1/1/2000
• Hyperkinetic movement disorders - a four-article symposium  
  Caviness JN, Postgrad Med, 1/1/2000
• The Huntington Study Group Rate of functional decline in Huntington’s disease  
  Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB, Siemers E, Shoulson I, Caviness JN, Neurology, 1/1/2000
• Physiological classification of myoclonus  
  Caviness JN, Sociedad Iberoamericana de Information Cientifica, 1/1/1998
• Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controled, parallel-group study  
  Lieberman A, Caviness JN, The Pramipexole Study Group, Neurology, 1/1/1997
• Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations - a multicenter, double blind, ...  
  Kurth MC, Adler CH, Sthilaire M, Singer C, Waters C, Lewitt P, Chernik DA, Dorflinger EE, Yoo K, Lieberman AN, Brewer M, Sainthilaire M, Pery LM, Thomas C, Turpin L, O..., Neurology, 1/1/1997
• Join now to see all

Books/Book Chapters

• Hyperkinetic movement disorders: differential diagnosis and treatment 
  Chapter: Segmental myoclonus 
  Page 221 - 235Caviness JNEditors: Albanese A; Jankovic J.Wiley-Blackwell, Hooboken, NJ2012
• Atlas of video-EEG monitoring 
  Chapter: Epileptic myoclonus 
  Page 309 - 328Caviness JNEditors: Sirven JI; Stern JM.McGraw-Hill Medical, New York, NY2011
• International neurology: a clinical approach 
  Chapter: Myoclonus 
  Page 179 - 183Caviness JN, Truong DD2010
• Clinical neurophysiology 
  Chapter: Movement-related cortical potentials and event-related potentials 
  Page 229 - 234Evidente VGH, Caviness JNEditors: Daube JR; Rubin DI.Oxford University Press, Oxford, EnglandEdition 3rd,2009
• Clinical neurophysiology 
  Chapter: Long latency reflexes and the silent period 
  Page 543 - 549Caviness JNEditors: Daube JR; Rubin DI.Oxford University Press, New York, NYEdition 3rd,2009
• The Encyclopedia of Oropharyngeal Dysphagia in Rare Conditions 
  Chapter: Lewy Body Dementia 
  Page 171 - 178Liss, J.M., Lansford, K., Caviness, J.N.Editors: J. Rosenbek.Plural Publishing, San Diego, CA2009
• Clinical neurophysiology 
  Chapter: Movement disorders 
  Page 551 - 573Caviness JNEditors: Daube JR; Rubin DI.Oxford University Press, New York, NYEdition 3rd,2009
• Handbook of Clinical Neurophysiology 
  Chapter: The clinical neurophysiology of myoclonus 
  Caviness JN2003
• National Organization for Rare Disorders 
  Chapter: Neuromuscular disorders: myoclonus 
  Page 627 - 628Caviness JNEditors: NORD guide to rare disorders.Lippincott Williams & Wilkins, Philadelphia, PA2003
• Handbook of Clinical Neurophysiology 
  Chapter: Clinical Neurophysiology of Myoclonus 
  Page 521 - 548Caviness JN2003
• Advanced Behavioral Biology 
  Chapter: Familial variants of Parkinson's Disease 
  Page 281 - 284Gwinn-Hardy K, Hanson M, Wszolek Z, Adam A, Singleton A, Adler CH, Caviness JN, Bower J, Hickey S, Chen JY, Waseem S, Farrer MEditors: Mizuno Y, Fisher A, Hanin I.Kluver Academic/Plenum Publishers, New York, NY2002
• Clinical neurophysiology 
  Chapter: Brain stem auditory evoked potentials in central disorders 
  Page 204 - 213Caviness JNEditors: Daube JR.Oxford University Press, Oxford, England2002
• Clinical neurophysiology 
  Chapter: Visual evoked potentials 
  Page 227 - 236Caviness JNEditors: Daube JR.Oxford University Press, Oxford, England2002
• Parkinson's Disease and Movement Disorders: Diagnosis and Treatment Guidelines for the Practicing Physician 
  Chapter: Huntington's disease and other choreas 
  Page 321 - 330Caviness JNEditors: Adler CH, Ahlskog JE.Humana Press, Totowa, NJ2000
• Parkinson's Disease and Movement Disorders: Diagnosis and Treatment Guidelines for the Practicing Physician 
  Chapter: Myoclonus 
  Page 339 - 350Caviness JNEditors: Adler CH, Ahlskog JE.Humana Press, Totowa, NJ2000
• Function and Regulation of Monoamine Enzymes: Basic and Clinical Aspects 
  Chapter: Direct amperometric measurement of the rate of release of dopamine from superfused brain tissue 
  Wightman RM, Caviness JN, Hmelovsky AMEditors: Usdin E.Macmillan Publishing Co., London, UK1982
• Join now to see all

Abstracts/Posters

• Elderly onset essential tremor and cognitive impairment
  Caviness JN, Movement Disorders Congress, San Diego, CA, 1/18/2015
• Longitudinal EEG changes correlate with decreased cognitive performance in PD
  Caviness JN, Hentz J, Adler CH, Shill HA, Neurology, 1/1/2014
• Co-existant PSP and PD pathology
  Rigby H, Duggar B, Adler CH, Shill HA, Beach TG, Caviness JN, Neurology, 1/1/2014
• Early diagnosis of PD: Clinicopathologic accuracy
  Early diagnosis of PD: Clinicopathologic accuracy, Neurology, 1/1/2014
• Neuropathological outcome of prospectively followed normal elderly brain bank volunteers
  Neuropathological outcome of prospectively followed normal elderly brain bank volunteers, J Neuropathol Exp Neurol, 1/1/2013
• Concomitant pathologies among a spectrum of parkinsonian disorders
  Dugger B, Adler C, Shill H, Caviness J, Jacobson S, Driver-Dunckley E, Beach T, J Neuropathol Exp Neurol, 1/1/2013
• Results of the citalopram to enhance cognition in hd trial
  Beglinger L, Adams W, Langbehn D, Fiedorowicz J, Jorge R, Biglan K, Caviness J, Olson B, Robinson R, Keiburtz K, Paulsen J, Neurother, 1/1/2013
• Does Hashimoto's Thyroiditis Predispose to Cerebellar Ataxia in Essential Tremor Patients Undergoing Thalamic Stimulation?
  Shneyder N, Evidente VGH, Adler CH, Caviness JN, Hentz JG, American Academy of Neurology Meeting, Honolulu, HI, 1/1/2011
• Excessive wrist rotation in golfer’s cramp
  Adler CH, Crews D, Kahol K, Santello M, Noble B, Caviness JN, American Academy of Neurology Meeting, Honolulu, HI, 1/1/2011
• Increased frequency of REM sleep behavior disorder in Parkinson’s disease but not in RLS or essential tremor
  Adler CH, Hentz JG, Sabbagh MN, Shill HA, Evidente VGH, Driver-Dunckley E, Jacobson SA, Beach TG, Boeve B, Caviness JN, American Academy of Neurology 63rd Annual Meeting, Honolulu, HI, 1/1/2011
• Autonomic Dysfunction occurs in patients with Restless Legs Syndrome
  Shneyder N, Driver-Dunckley ED, Hentz JG, Shill H, Caviness JN, Sabbagh MN, Beach T, Adler CH, American Academy of Neurology 63rd Annual Meeting, Honolulu, HI, 1/1/2011
• Autonomic function is normal in Essential Tremor but not Parkinson's Disease. 1965AAN11D1
  Damian AN, Driver-Dunckley E, Hentz JG, Shill HA, Caviness JN, Sabbagh MN, Beach TG, Adler CH, American Academy of Neurology 63rd Annual Meeting, Honolulu, HI, 1/1/2011
• Quantitative electroencephalography as a predictor for Parkinson's disease dementia
  Klassen B, Hentz J, Adler CH, Shill H, Driver-Dunckley E, Evidente V, Sabbagh M, Caviness JN, Mov Disord, 1/1/2010
• Post-operative medication doses are reduced equally in Parkinson's patients who undergo either bilateral pallidal or subthalamic deep-brain stimulation
  Premkumar A, Lyons M, Hillman R, Falk B, Lemens S, Wheeler M, Caviness J, Driver-Dunckley E, Adler C, Evidente V, J Neurol, 1/1/2008
• Neuropathologic findings in patients with Parkinson's disease and mild cognitive impairment
  Adler C, Connor D, Sabbagh M, Beach T, Shill H, Vedders L, Sue L, Caviness J, J Neurol, 1/1/2008
• High specificity and sensitivity of olfactory bulb synucleinopathy for lewy body disorders
  Beach TG, White CL, Hladik C, Sabbagh MN, Connor DJ, Caviness JN, Sue LI, Sasse J, Bachalakuri J, Akiyama H, Adler CH, J Neuropathol Exp Neurol, 1/1/2008
• Motor and cognitive findings in incidental Lewy body disease
  Beach TG, Connor DJ, Sue LI, Caviness JN, Sabbagh MN, Adler CC, J Neuropathol Exp Neurol, 1/1/2007
• Motor and cognitive findings in incidental Lewy body disease
  Beach TG, Connor DJ, Sue LI, Caviness JN, Sabbagh MN, Adler CC, FASEB J, 1/1/2007
• Predicting clinically probable Parkinson's disease
  Adler CH, Caviness JN, Sabbagh M, Connor D, Hentz J, Shill H, Evidente VG, Silverberg N, Hernandez J, Joyce J, Mahant P, Samanta J, Burns RS, Driver-Dunckley E, Beach T, Neurology, 1/1/2006
• Functional decline correlates with cognitive impairment in AD and PD
  Sabbagh MN, Lahti T, Connor DJ, Caviness JN, Shill HA, Mahant P, Samanta J, Burns RS, Evidente VG, Driver Dunckley E, Bonner LT, Reisberg B, Bircea S, Adler CH, Ann Neurol, 1/1/2006
• Clinical and pathologic findings in PD with LRRK2 mutations: 2 cases with mild cognitive impairment and small amplitude myoclonus
  Adler CH, Grover AC, Sabbagh MN, Caviness JN, Connor DJ, Beach TG, Mov Disord, 1/1/2006
• Quantitative electroencephalography can distinguish between Parkinson's disease patient groups classified according to clinical cognitive dysfunction and neuropsychome...
  Caviness JN, Sabbagh M, Conner D, Hentz J, Evidente VG, Driver-Dunckley E, Samanta J, Mahant P, Shill H, Adler C, Neurology, 1/1/2006
• Olfactory resting in Parkinson's disease and other movement disorders: correlation with Parkinsonian severity
  Adler CH, Caviness JN, Sabbagh M, Hentz JG, Evidente VGH, Shill H, et al, Mov Disord, 1/1/2005
• Mild cognitive impairment and Parkinson's disease
  Driver-Dunckley ED, Caviness JN, Adler CH, Sabbagh M, Connor D, Shill H, Hernandez J, Evidente VGH, Neurology, 1/1/2005
• Comptocormia in Parkinson's disease is responsive to bilateral subthalamic stimulation
  Evidente VGH, Driver-Dunckley E, Hillman R, Caviness JN, Lyons MK, Neurology, 1/1/2005
• Join now to see all

Lectures

• Unawareness of hyposmia in elderly people with and without Parkinson's disease 
  San Diego, CA - 1/18/2015
• Mechanism and therapeutics of myoclonus 
  Dallas, TX - 1/13/2015
• REM sleep behavior disorder and neuropathology in Parkinson’s disease 
  1/1/2015
• Unawareness off hyposmia in elderly people with and without Parkinson’s disease 
  1/1/2015
• Elderly onset essential tremor and cognitive impairment 
  1/1/2015
• Network analysis of resting state EEG recordings: detecting acute and residual effects of concussion 
  1/1/2015
• Update on Huntington’s Disease 
  Prescott, AZ - 1/29/2014
• Early diagnosis of PD: Clinicopathologic accuracy 
  Philadelphia, PA - 1/1/2014
• Co-existant PSP and PD pathology 
  Philadelphia, PA - 1/1/2014
• Longitudinal EEG changes correlate with decreased cognitive performance in PD 
  Philadelphia, PA - 1/1/2014
• Update on Research in Huntington’s Disease 
  Prescott, AZ - 1/30/2013
• Pathophysiology of Parkinson’s Disease Behavior 
  Geneva, Switzerland - 1/9/2013
• New Treatments for Parkinson’s disease 
  Santa Barbara, CA - 1/1/2013
• Cortical Myoclonus 
  Shanghai, People's Republic of China - 1/10/2011
• Hyperkinetic Movement Disorders 
  Shanghai, People's Republic of China - 1/10/2011
• Preclinical Parkinson’s Disease 
  Shanghai, People's Republic of China - 1/10/2011
• Electrophysiological Biomarkers of Incidental Lewy Body Disease 
  Honolulu, HI - 1/1/2011
• Clinical Evaluation and Treatment of Myoclonus 
  Miami, FL - 1/11/2009
• Research Update for Huntington’s Disease 
  Prescott, AZ - 1/21/2007
• Myoclonus - State of the Art and Future Directions 
  Amsterdam, The Netherlands - 1/12/2007
• Diagnosis and Treatment of Parkinson’s Disease 
  Big Island, HI - 1/3/2007
• “Myoclonus” and “Chorea” 
  Kauai, HI - 1/1/2007
• Brainstem Anatomy (Cranial Nerves Overview), Cerebellar Anatomy, Basal Ganglia, Thalamus 
  Phoenix, AZ - 1/30/2005
• Neuronal Structure, Chemical Synapse, Impulse Conduction 
  Phoenix, AZ - 1/30/2005
• Introduction to Cortical Anatomy; Functional Areas of Cortex 
  Phoenix, AZ - 1/23/2005
• Join now to see all

Other

• Classification and evaluation of myoclonus 
  Caviness JN
  http://www.uptodate.com/contents/classification-and-evaluation-of-myoclonus
  UpToDate, Wolters Kluwer Health - 2012-09-18
• Symptomatic (secondary) myoclonus 
  Caviness JN
  http://www.uptodate.com/contents/symptomatic-secondary-myoclonus
  UpToDate, Wolters Kluwer Health - 2012-09-18
• Treatment of myoclonus 
  Caviness JN
  http://www.uptodate.com/contents/treatment-of-myoclonus
  UpToDate, Wolters Kluwer Health - 2012-06-19
• Classification of Myoclonus 
  Caviness JN, Up To Date
• Myoclonus 
  Caviness JN, Medlink
• Join now to see all